Guobang Pharma Ltd.SSE: 605507

(605507)"Guobang Pharma Ltd."Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report

· Issued by Guobang Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605507 · · 8 pages · Chinese

Summary by 6ix AI

Guobang Pharma Ltd. has announced a share repurchase plan through a call auction, detailing the intended use of funds and the maximum price per share. The company plans to repurchase shares using its own funds, with a total amount not less than a specified minimum and not exceeding a specified maximum. The repurchase is aimed at maintaining company value and protecting shareholder interests, with a defined timeframe for execution. The filing outlines potential risks associated with the repurchase, including market price fluctuations and regulatory changes.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/605507guobang-pharma-ltdannouncement-on-share-repurchase-plan-through-call-auction-and-the-repurchase-report

Release

Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:

Guobang Pharma Ltd. on 6ix

Story so far

Earlier from Guobang Pharma

Later from Guobang Pharma

All Guobang Pharma news releases